Interni hematoonkologicka klinika

Brno 625 00

0 studies enrolling now · 2 studies all time

What they study most

B-cell Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin

Studies at this site

• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Following Second Line Therapy — Completed